Inosine Monophosphate Dehydrogenase Type II from Human, Recombinant

inquiry

Cat No.

NATE-0352

Description

Type II is the predominant IMPDH isoform and is specifically linked to a wide range of cancers and lymphocyte proliferation.

Abbr

IMPDH2, Recombinant (Human)

Alias

IMPDH II; IMPDH2; IMPD 2

Source

E. coli

Species

Human

Package

vial of > 0.002 unit

Form

Solution in 20 mM Tris-HCl, pH 8.0, containing 0.5 mM EDTA and 1 mM DTT.

Enzyme Commission Number

EC 1.1.1.205

CAS_No

231-791-2

Unit Definition

One unit will produce 1.0 μ mole of XMP from IMP with corresponding reduction of β-NAD per minute at pH 8.0 at 25°C.

Storage

−70°C

Pathway

Drug metabolism-other enzymes, organism-specific biosystem; Drug metabolism-other enzymes, conserved biosystem; Metabolic pathways, organism-specific biosystem; Metabolism, organism-specific biosystem; Metabolism of nucleotides, organism-specific biosystem; Purine metabolism, organism-specific biosystem; Purine metabolism, organism-specific biosystem

Function

DNA binding; IMP dehydrogenase activity; RNA binding; metal ion binding; nucleotide binding; oxidoreductase activity

Synonyms

inosine-5'-phosphate dehydrogenase; inosinic acid dehydrogenase; inosinate dehydrogenase; inosine 5'-monophosphate dehydrogenase; inosine monophosphate dehydrogenase; IMP oxidoreductase; inosine monophosphate oxidoreductase; IMP dehydrogenase; IMP:NAD+ oxidoreductase; EC 1.1.1.205; IMPDH II; IMPDH2; IMPD 2

"IMPDH2" Total Products Page

Enzymes

Catalog	Product Name	EC No.	CAS No.	Source	Price
NATE-1739	Inosine Monophosphate Dehydrogenase from Staphylococcus aureus, Recombinant	EC 1.1.1.205	9028-93-7	S. aureus	Inquiry
EXWM-0109	IMP dehydrogenase	EC 1.1.1.205	9028-93-7		Inquiry

Name:

Email *

Phone:*

Company/Institution:

Country or Region:

Quantity:

Services & Products Interested *

Project Description:

Our Products Cannot Be Used As Medicines Directly For Personal Use.

Products

Online Inquiry